Agile Therapeutics Inc. announced the launch of the women’s healthcare company’s first consumer commercial intended to increase awareness of the Twirla weekly birth control patch.
The U.S. Senate on February 15 voted to confirm Dr. Robert Califf as commissioner of the U.S. Food and Drug Administration after some senators had argued his ties to the pharmaceutical industry or views on birth control made him unfit for the role.
McCann Health New Jersey is launching a new campaign for Evofem Biosciences Inc.’s revolutionary hormone-free birth control product, Phexxi. Starring Emmy® Award winning actress Annie Murphy, the cheeky and flirty campaign “House Rules” was led by an all-female creative, strategy and account team.
Evofem Biosciences Inc. announced the launch of “Get Phexxi”, a national direct-to-consumer (DTC) campaign aimed at broadening awareness of the company’s non-hormonal, use-it-only-when-you-need-it birth control method, Phexxi (lactic acid, citric acid and potassium bitartrate).
The U.S. Food and Drug Administration approved Evofem Biosciences Inc.’s Phexxi (lactic acid, citric acid and potassium bitartrate) vaginal gel for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception.
The U.S. Supreme Court considered a bid by Donald Trump’s administration to implement rules allowing employers to obtain religious exemptions from an Obamacare requirement that health insurance that they provide to employees covers women’s birth control.
Amphora has the opportunity to completely disrupt the birth control market with a new viscous and bioadhesive contraceptive.
Bayer shares fell by as much as 5 percent after a California couple were awarded more than $2 billion in the largest U.S. jury penalty over allegations the company’s Roundup weed killer causes cancer.
The U.S. Food and Drug Administration approved a new protocol for a post-marketing study of Bayer AG’s Essure birth-control device, as the regulator seeks more information on the device’s safety.
Bayer will discontinue the sale of the healthcare company’s birth control product Essure in the United States.